BackSummit Therapeutics Overview
stock.name

Summit Therapeutics Target Price

Analysts' 12-month price predictions for SMMT.

Share Price

$4.44

Average Target Price

$8.0080.2% upside

1 analysts in the last 4 months

High: $8 | Low: $8

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-03-25Stifel NicolausBrad Canino$880.2% upsideOpen